Search

everythinglearnresearchcommunity

for

Search:↓

Only minoxidil and finasteride are FDA-approved for hair loss, with other treatments available but less effective or with side effects.

Androgenic alopecia, a common hair loss condition, is linked to changes in androgen metabolism and genetics, and can be treated with finasteride and minoxidil, but these treatments are only fully effective in 10% of patients.

Androgenetic alopecia, or hair loss, is caused by a mix of genetics, hormones, and environment, where testosterone affects hair growth and causes hair to become smaller and grow for a shorter time.

Male pattern baldness involves genetics, hormones, and needs better treatments.

Hair loss involves immune responses, inflammation, and disrupted signaling pathways.

The document concludes that accurate diagnosis and personalized treatment are important for skin problems in women with PCOS.

Diagnosing sex development disorders requires combining medical history, physical exams, imaging, lab tests, and genetic data.

Female Pattern Hair Loss affects women's self-esteem and needs more research for better treatment.

High-content screening is useful for finding new treatments for rare diseases and has led to FDA-approved drugs.

Certain skin conditions can indicate insulin resistance and should prompt lifestyle changes and medical treatment to manage underlying health issues.

Hormones affect skin aging, and treatments targeting hormonal balance may improve skin health.

The review suggests that while many AKR1C3 inhibitors show promise for treating certain cancers, more research is needed to confirm their effectiveness in humans.

Hormonal imbalances can cause hair loss, and understanding them can help develop better treatments.

Cutaneous Lymphadenoma is a unique skin tumor with specific protein markers and common gene mutations that may cause continuous cell growth.

Mutations in the androgen receptor gene cause Androgen Insensitivity Syndrome, affecting sexual development.

Mutations in the androgen receptor gene cause different levels of androgen insensitivity, making it hard to create simple tests for the condition.

Kennedy's disease leads to muscle weakness and sensory issues, has no cure but manageable symptoms, and future treatments look promising.

The length of the CAG repeat in the androgen receptor gene affects the risk and progression of prostate cancer, BPH, infertility, and undermasculinized genitalia.

Testing for CAG repeat polymorphism in the androgen receptor gene is not currently recommended for managing hypogonadism.

Genetic variation in the androgen receptor gene mainly causes early-onset hair loss, with maternal inheritance playing a key role.

Certain genetic variations in the AR and ERβ genes can affect androgen levels in women.

Reduced AR gene methylation may cause early pubic hair growth in girls.

Longer CAG repeat lengths in the androgen receptor gene are linked to higher testosterone levels in women with PCOS.

G allele of AR Stul polymorphism linked to higher hair loss risk, especially in white people.

Blocking the androgen receptor in skin cells reduces their growth response to male hormones, suggesting a possible treatment for skin conditions linked to androgens.

Scientists have developed a new method to detect steroid abuse in athletes using cell-based tests, which could be the future of anti-doping methods.

Longer CAG and GGN repeats increase alopecia risk, but no significant link to post-finasteride syndrome found.

Finasteride side effects in young men may be linked to specific gene variations.

Changes in testosterone and estrogen receptor genes can affect how men age, influencing body fat, hair patterns, and possibly leading to skin disorders.

DHT affects bone growth by altering gene activity in osteoblasts, potentially complicating steroid use.